NovaDel Pharma Inc. Company Profile

17:43 EST 27th February 2015 | BioPortfolio

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly reduced first pass liver metabolism, which may result in lower doses. Oral sprays eliminate the requirement for water or the need to swallow, potentially improving patient convenience and adherence.


News Articles [856 Associated News Articles listed on BioPortfolio]

NovaDel sells ZolpiMist NDA, license and intellectual property to Amherst Pharma

US-based NovaDel Pharma has sold its ZolpiMist new drug application (NDA) to Amherst Pharmaceuticals as part of its intention to liquidate the company or seek another business opportunity.

NovaDel sells ZolpiMist NDA, license and IP to Amherst Pharma

NovaDel Pharma has sold its insomnia drug ZolpiMist (zolpidem oral spray) New Drug Application to fellow USA-based Amherst Pharmaceuticals.

NovaDel Pharma sells remaining assets of ZolpiMist NDA to Amherst for $2.2m

As previously reported, NovaDel Pharma has sold its remaining assets, which consisted of the ZolpiMist NDA, a license agreement and related global intellectual property to Amherst Pharmaceuticals in e...

NovaDel Announces the Sale of Its ZolpiMist® New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC

NovaDel Pharma Inc. (NVDL.PK) has sold its ZolpiMist® New Drug Application to Amherst Pharmaceuticals, LLC. The transaction also includes the NovaDel patents and trademarks cover...

NovaDel Announces Update to Agreement with Amherst Pharmaceuticals

As previously reported, NovaDel Pharma, Inc. (NVDL.PK) has sold its remaining assets, which consisted of the ZolpiMist® NDA, a license agreement and related global intellectual p...

VERONA PHARMA PLC - CMO appointment & incorporation of Verona Pharma Inc

Verona Pharma plc ("Verona Pharma" or the "Company") Appointment of Dr Kenneth Newman as Chief Medical Officer and Incorporation of Verona Pharma, Inc. 17 December 2014, Cardiff - Verona Pharma pl...

Deal Notes: GlycoMimetics/Pfizer, Pharmacyclics/Servier, TG Therapeutics/Rhizen, Takeda/BioMotiv, Amherst/NovaDel

Pfizer delays Phase III study with GlycoMimetics drug; Pharmacyclics, Servier end agreement; TG Therapeutics licenses drug from Rhizen; Takeda invests $25m in BioMotiv; and Amherst buys NovaDel's Zolp...

Omega Pharma rumored to be sought after by big pharma companies

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Inge...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Pharma corruption.

The premium of a big pharma license deal.

Pharma partners with efforts to pool patient genotype and phenotype data.

Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win-win-win) collaborations?

Biological complexity and the need for highly differentiated medicines means that drug discovery and development have become increasingly challenging and expensive. Thus, new paradigms for research an...

Best of Both Worlds: Combining Pharma Data and State of the Art Modeling Technology To Improve in Silico pKa Prediction.

In a unique collaboration between a software company and a pharmaceutical company, we were able to develop a new in silico pKa prediction tool with outstanding prediction quality. An existing pKa pred...

Clinical Trials [45 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [648 Associated Companies listed on BioPortfolio]

Novadel Pharma, Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company that previously developed oral spray formulations of marketed pharmaceutical products. The Company has discontinued its o...

NovaDel Pharma

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments for serious diseases. The Company’s proprietary technology enabl...

NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers,...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "NovaDel Pharma Inc." on BioPortfolio

We have published hundreds of NovaDel Pharma Inc. news stories on BioPortfolio along with dozens of NovaDel Pharma Inc. Clinical Trials and PubMed Articles about NovaDel Pharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovaDel Pharma Inc. Companies in our database. You can also find out about relevant NovaDel Pharma Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record